Therefore, integrin αvβ6 interacts with pro-invasive membrane proteins at the tumor edge, e.g. the TGFβ type II receptor and the urokinase receptor, thereby promoting the proteolytic actions of TGFβ1 at the invasive tumor front [20, 25]. The gene discussed is TGFB1; the disease is neoplasm.